Teaching Old Drugs New Tricks: Statins for COVID-19?
Cell Metab
; 32(2): 145-147, 2020 08 04.
Article
in English
| MEDLINE | ID: covidwho-691958
ABSTRACT
The COVID-19 pandemic has driven unprecedented efforts to identify existing treatments that can be quickly and effectively repurposed to reduce morbidity and mortality. In this issue of Cell Metabolism, Zhang et al. (2020) report an association between statin use and improved outcomes in a large observational study of hospitalized COVID-19 patients. Given the widespread availability, low cost, and safety of statins, this promising result should be further investigated in randomized controlled trials.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Hydroxymethylglutaryl-CoA Reductase Inhibitors
/
Drug Repositioning
/
Betacoronavirus
Type of study:
Experimental Studies
/
Observational study
/
Prognostic study
/
Randomized controlled trials
Limits:
Humans
Language:
English
Journal:
Cell Metab
Journal subject:
Metabolism
Year:
2020
Document Type:
Article
Affiliation country:
J.cmet.2020.07.006
Similar
MEDLINE
...
LILACS
LIS